-
European Journal of Heart Failure Jul 2017
Topics: Heart Failure; Humans; Stroke Volume; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right
PubMed: 27860059
DOI: 10.1002/ejhf.691 -
Minerva Anestesiologica Jun 2008
Review
Topics: Child; Heart Failure; Humans; Intensive Care Units, Pediatric; Ventricular Dysfunction
PubMed: 18500204
DOI: No ID Found -
Khirurgiia 2017
Review
Topics: Cardiac Surgical Procedures; Disease Management; Humans; Practice Guidelines as Topic; Tetralogy of Fallot; Ventricular Dysfunction, Right; Ventricular Remodeling
PubMed: 28638021
DOI: 10.17116/hirurgia2017684-90 -
European Heart Journal Jun 2016
Topics: Cachexia; Heart Failure; Humans; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right
PubMed: 27071817
DOI: 10.1093/eurheartj/ehw118 -
Heart Failure Monitor 2002Over 4.7 million Americans have heart failure, and 50000 new cases of heart failure are diagnosed every year. In addition, a significant proportion of the population may... (Review)
Review
Over 4.7 million Americans have heart failure, and 50000 new cases of heart failure are diagnosed every year. In addition, a significant proportion of the population may have asymptomatic left ventricular (LV) systolic dysfunction. Population studies estimate that the prevalence of asymptomatic LV dysfunction ranges from 0.9-5.9%. Of these, a substantial number will eventually develop symptomatic heart failure. Diagnosing and treating these patients before they develop symptoms may help to delay or prevent the development of symptomatic heart failure. This review highlights the currently available data on the epidemiology, pathophysiology, diagnosis, and treatment of asymptomatic LV systolic dysfunction.
Topics: Female; Heart Failure; Humans; Male; Prevalence; Prognosis; Risk Factors; Ventricular Dysfunction, Left
PubMed: 12634879
DOI: No ID Found -
Congestive Heart Failure (Greenwich,... 2007It is well recognized that patients with severe left ventricular (LV) systolic dysfunction develop pulmonary venous hypertension or postcapillary pulmonary hypertension,... (Review)
Review
It is well recognized that patients with severe left ventricular (LV) systolic dysfunction develop pulmonary venous hypertension or postcapillary pulmonary hypertension, which leads to an increase in pulmonary vascular resistance (PVR) and right ventricular (RV) systolic failure. It is often underrecognized, however, that patients with heart failure with preserved LV ejection fraction and diastolic dysfunction may also develop postcapillary pulmonary hypertension with elevated PVR leading to RV systolic failure. This form of biventricular failure is a result of diastolic failure on the left in patients with preserved LV ejection fraction and systolic failure on the right. At this time, there are no randomized trials or guidelines addressing the management of patients with diastolic heart failure with and without resultant RV failure. The authors review the pathophysiology, clinical presentation, and suggested treatment of this underrecognized clinical entity.
Topics: Biomarkers; Diastole; Heart Failure; Humans; Hypertension, Pulmonary; Natriuretic Peptide, Brain; Pulmonary Wedge Pressure; Stroke Volume; Vascular Resistance; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right
PubMed: 17541311
DOI: 10.1111/j.1527-5299.2007.06408.x -
Circulation. Arrhythmia and... Dec 2019AF-mediated cardiomyopathy (AMC) is an important reversible cause of heart failure that is likely underdiagnosed in today's clinical practice. AMC describes AF either as... (Review)
Review
AF-mediated cardiomyopathy (AMC) is an important reversible cause of heart failure that is likely underdiagnosed in today's clinical practice. AMC describes AF either as the sole cause for ventricular dysfunction or exacerbating ventricular dysfunction in patients with existing cardiomyopathy or heart failure. Studies suggest that irreversible ventricular and atrial remodeling can occur in AMC, making timely diagnosis and intervention critical to optimize clinical outcome. Clinical correlation between AF onset/burden and progression of cardiomyopathy/heart failure symptoms provides strong evidence for the diagnosis of AMC. Cardiac MRI, continuous cardiac monitoring, and biomarkers are important diagnostic tools. From the therapeutic standpoint, early data suggest that AF ablation may improve long-term outcomes in AMC patients compared with medical rate and rhythm control. Patients with more AF burden and less severe underlying structural heart disease are more likely to experience left ventricle function recovery with successful AF ablation. Despite recent advances, significant knowledge gaps exist in our understanding of the epidemiology, mechanisms, diagnosis, management strategies, and prognosis of AMC.
Topics: Atrial Fibrillation; Atrial Remodeling; Cardiomyopathies; Clinical Decision-Making; Death, Sudden, Cardiac; Humans; Prevalence; Prognosis; Risk Factors; Ventricular Dysfunction; Ventricular Remodeling
PubMed: 31826649
DOI: 10.1161/CIRCEP.119.007809 -
Seminars in Perinatology Feb 2020There is increasing evidence that cardiac dysfunction is a key contributor to CDH pathophysiology. Dysfunction in both right and left ventricles is common in the early... (Review)
Review
There is increasing evidence that cardiac dysfunction is a key contributor to CDH pathophysiology. Dysfunction in both right and left ventricles is common in the early neonatal period, contributes to clinical disease severity, and is associated with adverse outcomes including death and ECMO use. Early and routine assessment of ventricular function and pulmonary artery pressure may guide individualized clinical decision-making, including use of pulmonary vasodilators, cardiotropes, ECMO, and timing of surgical repair. Minimizing cardiac dysfunction, whether by prenatal, postnatal or perinatal treatment strategies, may lead to improved outcome in CDH.
Topics: Cardiotonic Agents; Echocardiography; Extracorporeal Membrane Oxygenation; Hernias, Diaphragmatic, Congenital; Humans; Hypertension, Pulmonary; Infant, Newborn; Lung; Plastic Surgery Procedures; Vascular Resistance; Vasodilator Agents; Ventricular Dysfunction
PubMed: 31420110
DOI: 10.1053/j.semperi.2019.07.007 -
Nephrology, Dialysis, Transplantation :... 1998
Review
Topics: Blood Pressure; Diastole; Humans; Ventricular Dysfunction, Left
PubMed: 9614655
DOI: 10.1093/ndt/13.suppl_4.3 -
Journal of Cardiothoracic and Vascular... Feb 2001With the recognition of the clinical importance of the right ventricle; the development of new techniques for the perioperative evaluation of RV function, particularly... (Review)
Review
With the recognition of the clinical importance of the right ventricle; the development of new techniques for the perioperative evaluation of RV function, particularly transesophageal echocardiography; and new treatment modalities (pharmacologic and mechanical), clinicians will be able to more accurately diagnose and precisely manage patients who have sustained RV injury.
Topics: Assisted Circulation; Humans; Intraoperative Complications; Ventricular Dysfunction
PubMed: 11254849
DOI: 10.1053/jcan.2001.20283